产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
---|---|---|---|---|
D937589 | 1263303-95-2 | (E)-2-([1,1'-Biphenyl]-4-ylamino)-N-hydroxy-2-oxoacetimidoyl cyanide, ≥99% DHODH-IN-11, ≥99% |
C15H11N3O2 | |
T938268 | 934358-00-6 | (E)-3-(2,3,4,5-Tetrabromophenyl)acrylic acid, ≥99% TBCA, ≥99% |
C9H4Br4O2 | |
T938241 | 1148118-92-6 | (E)-Tripolin A, ≥98% Tripolin A, ≥98% |
C15H11NO3 | |
E933663 | 694522-87-7 | (E/Z)-GO289, ≥98% (E/Z)-GO289, ≥98% |
C17H15BrN4O2S | |
E933718 | 3367-88-2 | (E/Z)-GSK-3β inhibitor 1, 98% (E/Z)-GSK-3β inhibitor 1, 98% |
C14H10N2O | |
M797952 | 1435265-06-7 | (R)-2-((S)-2-苯甲酰胺-3-(1H-吲哚-3-基)丙酰胺基)-3-苯基丙酸甲酯, 10mM in DMSO Methyl benzoyl-L-tryptophyl-D-phenylalaninate, 10mM in DMSO |
C28H27N3O4 | |
M887666 | 1435265-06-7 | (R)-2-((S)-2-苯甲酰胺-3-(1H-吲哚-3-基)丙酰胺基)-3-苯基丙酸甲酯, 98% Methyl benzoyl-L-tryptophyl-D-phenylalaninate, 98% |
C28H27N3O4 | |
R793669 | 266359-83-5 | (R)-2-(4-异丁基苯基)-N-(甲基磺酰基)丙酰胺, 10mM in DMSO Reparixin (Repertaxin), 10mM in DMSO |
C14H21NO3S | |
D937575 | 13095-47-1 | (R)-2-Hydroxyglutarate, 98% D-α-Hydroxyglutaric acid, 98% |
C5H8O5 | |
R872216 | 947303-87-9 | (R)-4-((二乙基胺)甲基)-N-(2-甲氧基苯乙基)- 4-[(二乙基氨基)甲基]-N-[2-(2-甲氧基苯基)乙基]-N-(3R)-3-吡咯烷基苯甲酰胺 二盐酸盐, 98% (R)-4-((Diethylamino)methyl)-N-(2-methoxyphenethyl)-N-(pyrrolidin-3-yl)benzamide dihydrochloride, 98% |
C25H35N3O2 (free base) | |
R798207 | 947303-87-9 | (R)-4-((二乙基胺)甲基)-N-(2-甲氧基苯乙基)- 4-[(二乙基氨基)甲基]-N-[2-(2-甲氧基苯基)乙基]-N-(3R)-3-吡咯烷基苯甲酰胺 二盐酸盐, 10mM in DMSO (R)-4-((Diethylamino)methyl)-N-(2-methoxyphenethyl)-N-(pyrrolidin-3-yl)benzamide dihydrochloride, 10mM in DMSO |
C25H35N3O2 (free base) | |
R938289 | 18426-17-0 | (R)-6-Allyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol, ≥98% R(-)-N-Allylnorapomorphine, ≥98% |
C19H19NO2 | |
O872272 | 1338540-63-8 | (R)-9-(4-(1-氨基丙-2-基)苯基)-8-羟基-6-甲基噻吩并[2,3-c]喹啉-4(5H)-酮, 99% (R)-9-(4-(1-aminopropan-2-yl)phenyl)-8-hydroxy-6-methylthieno[2,3-c]quinolin-4(5H)-one, 99% |
C21H20N2O2S | |
R877165 | 834153-87-6 | (R)-Elagolix, 98% (R)-Elagolix, 98% |
C32H30F5N3O5 | |
R876780 | 885060-08-2 | (R)-Filanesib, ≥98% (R)-Filanesib, ≥98% |
C20H22F2N4O2S | |
R873495 | 2003234-63-5 | (R)-GNE-140, 98% (R)-GNE-140, 98% |
C25H23ClN2O3S2 | |
R937751 | 1793050-70-0 | (R)-Gyramide A hydrochloride, ≥98% (R)-Gyramide A hydrochloride, ≥98% |
C21H28ClFN2O3S | |
R793382 | 1211877-36-9 | (R)-MG132, 10mM in DMSO (R)-MG132, 10mM in DMSO |
C26H41N3O5 | |
R873167 | 1211877-36-9 | (R)-MG132, ≥98% (R)-MG132, ≥98% |
C26H41N3O5 | |
R872558 | 195881-94-8 | (R)-Nepicastat HCl, 99% RS-25560-198 HCl, 99% |
C14H15F2N3S·HCl |